AHFS Drug Information (AHFS DI) is a leading source of evidence-based drug information.

AHFS DI is a dependable, comprehensive and objective database for FDA approved drug products. Inclusion of evidence-based data on labelled and unlabelled drug use makes this a valuable reference for healthcare professionals seeking to provide their patients with safe and effective therapy.

AHFS DI is published by the American Society of Health-System Pharmacists (ASHP).

SubscribeContent Updates
Features and Benefits icon

Comprehensive: Highly detailed monographs with extensive information on the chemistry and clinical application of all FDA approved drugs

Features and Benefits icon

Evidence-based: Built on evidence from primary sources and peer reviewed by over 500 pharmacists, physicians and healthcare professionals

Features and Benefits icon

Dependable: Fast and easy access to content that is revalidated, revised and updated regularly as new information arrives

Features and Benefits icon

Objective: The information is compiled without any influence from manufacturers, insurers, regulators or other interested parties

Publication Updates

12 Feb
AHFS Drug Information logo
AHFS Drug Information February 2019 update 

This update contains 5 new monographs, 8 revised monographs and 2 discontinued monographs.

New monographs: Cenegermin-bkbj; Emapalumab-lzsg; Larotrectinib; Glasdegib; Gilteritinib

Revised monographs: Pitavastatin; Azilsartan; Mepolizumab; Lutetium Lu 177 Dotatate; Megestrol; chlordiazePOXIDE; Fosfomycin; tiaGABine Hydrochloride

Discontinued monographs: Dasabuvir, Ombitasvir, Paritaprevir, and Ritonavir; Ombitasvir, Paritaprevir, and Ritonavir

15 Jan
AHFS Drug Information logo
AHFS Drug Information January 2019 update 

This update contains 6 new monographs and 45 revised monographs. 

New monographs: Inotersen; Moxetumomab Pasudotox-tdfk; Talazoparib; Baloxavir; Revefenacin; Lorlatinib

Revised monographs: Alosetron; Fluticasone; Oxcarbazepine; Candesartan; Olmesartan; Budesonide; Influenza Vaccine Live Intranasal; Dronabinol; Zoster Vaccine Live; Febuxostat; Rufinamide; Influenza Vaccine Recombinant; Macitentan; Patiromer; Zoster Vaccine Recombinant; Netarsudil; Codeine; Sodium Polystyrene Sulfonate; carBAMazepine; Loperamide; Codeine; HYDROcodone; Bupivacaine; Captopril; Amphetamines General Statement; Opiate Agonists General Statement; Thiazides General Statement; Local Anesthetics, Parenteral, General Statement; Insulins General Statement; dilTIAZem; NIFEdipine; Haemophilus b Vaccine; Enalapril; Benazepril; Ramipril; amLODIPine; Lisinopril; lamoTRIgine; Losartan; Influenza Virus Vaccine Inactivated; Meningococcal Groups A, C, Y, and W-135 Vaccine; OLANZapine; Topiramate; Valsartan; Irbesartan

 

11 Dec
AHFS Drug Information logo
AHFS Drug Information December 2018 update 

This update contains 8 new monographs, and 47 revised monographs. 

New monographs: Cannabidiol; Cemiplimab-rwlc; Dacomitinib; Galcanezumab-gnlm; Sarecycline; Duvelisib; Elapegademase-lvlr; Omadacycline

Revised monographs: Gemtuzumab; Formoterol; Zonisamide; Cisatracurium; Bendamustine; Lacosamide; Dolutegravir; Vilanterol; Pembrolizumab; Nivolumab; Ibrutinib; Evolocumab; Lumacaftor and Ivacaftor; Enasidenib; Glecaprevir and Pibrentasvir; DAUNOrubicin and Cytarabine; Inotuzumab; Abemaciclib; Acalabrutinib; Dolutegravir and Rilpivirine; Apalutamide; Tobramycin; Methotrexate; Cytarabine; Gentamicin; DAUNOrubicin; fentaNYL; Baclofen; Pancuronium; Succinylcholine; Dantrolene; vinCRIStine; Neuromuscular Blocking Agents General Statement; Verapamil; Atenolol; Atracurium; Amoxicillin; Penicillin G Benzathine; Penicillin G Potassium, Penicillin G Sodium; Penicillin G Procaine; Vecuronium; cefTRIAXone; Flecainide; Sotalol; Rocuronium; Salmeterol; Antiretroviral Agents General Statement 

13 Nov
AHFS Drug Information logo
AHFS Drug Information November 2018 update 

This update contains 12 new monographs, 41 revised monographs and 4 new MedWatch alerts. 

New monographs: Pilocarpine; Migalastat; Lusutrombopag; Sodium Zirconium Cyclosilicate; Tecovirimat; Stiripentol; Antihemophilic Factor (recombinant), PEGylated-aucl; Lanadelumab-flyo; Doravirine; Doravirine, Lamivudine, and Tenofovir Disoproxil; Eravacycline; Fremanezumab-vfrm 

Revised monographs: Bevacizumab; Maraviroc; Tapentadol; Canagliflozin; Dapagliflozin; Empagliflozin; Sofosbuvir, Velpatasvir, and Voxilaprevir; Neratinib; Meropenem and Vaborbactam; Ertugliflozin; Bictegravir, Emtricitabine, and Tenofovir Alafenamide; HYDROcodone; Rabies Vaccine; HYDROmorphone; Levorphanol; Codeine; oxyMORphone; oxyCODONE; Morphine; Methadone; Promethazine; Pentazocine; fentaNYL; Doxylamine; Butorphanol; Nalbuphine; Promethazine; Opiate Agonists General Statement; Antihistamines General Statement; Amoxicillin; Ampicillin; Penicillin V; Preface to Penicillins; Aminopenicillins General Statement; Buprenorphine; metroNIDAZOLE; Clarithromycin; traMADol; Immunization Schedules; Anti-infectives Available from CDC; Immunobiologic Agents Available from CDC 

New MedWatch alerts on the following monographs: Canagliflozin; Dapagliflozin; Empagliflozin; Ertugliflozin

08 Oct
AHFS Drug Information logo
AHFS Drug Information October 2018 update 

This update contains 7 new monographs, 13 revised monographs and 1 new MedWatch alerts. 

New monographs: Dehydrated Alcohol; Iobenguane I 131; Tildrakizumab-asmn; Patisiran; Tafenoquine; Glycopyrronium; Mogamulizumab-kpkc 

Revised monographs: Nevirapine; Enfuvirtide; Bortezomib; Methylnaltrexone; Regorafenib; Naloxegol; Naldemedine; Cyclophosphamide; DOXOrubicin; Aspirin; metroNIDAZOLE; Azithromycin; Thalidomide 

New MedWatch alerts on the following monographs: Azithromycin

14 Sep
AHFS Drug Information logo
AHFS Drug Information September 2018 Update

This update contains 7 new monographs, 35 revised monographs and 5 MedWatch Alerts. 

New monographs: Methoxy Polyethylene Glycol-epoetin Beta; Binimetinib; Encorafenib; Plazomicin; Darunavir, Cobicistat, Emtricitabine and Tenofovir Alafenamide; Ivosidenib; Elagolix 

Revised monographs: Moxifloxacin; Insulin Glargine; Gemifloxacin; Arformoterol; Indacaterol; Enzalutamide; Aclidinium; Vilanterol; Olodaterol; Umeclidinium; Lixisenatide; Sarilumab; Guselkumab; Theophyllines; HYDROmorphone; Erythromycin; Sulfacetamide Sodium; Terbutaline; Albuterol/Levalbuterol; Benztropine; Trihexyphenidyl; Procyclidine; Biperiden; Natamycin; Ephedrine; Ethosuximide; Clindamycin; Lincomycin; Isoproterenol; Hyoscyamine; Atropine; Ciprofloxacin; Ofloxacin; Salmeterol; levoFLOXacin 

New medwatch alerts on the following monographs: Moxifloxacin; Gemifloxacin; Ciprofloxacin; Ofloxacin; levoFLOXacin. 

View more View all content updates